GO
Loading...

Enter multiple symbols separated by commas

Amgen Inc

More

  • Election-Year Trades: Health Care Monday, 28 Jul 2008 | 5:53 PM ET

    Two strategists, Stephen Wood at Russell Investments and John Manley at Citi Smith Barney, shared their market rebound strategies with CNBC.

  • Dow Falls More Than 200 Points Monday, 28 Jul 2008 | 5:53 PM ET
    graphic_word_ofthe_street.jpg

    The Dow tumbled on Monday as more credit and housing market turmoil battered financial shares.

  • Amgen Earnings and Sales Rise, Top Forecasts Monday, 28 Jul 2008 | 5:11 PM ET
    Amgen

    Amgen reported a profit and sales that climbed higher and beat analysts' forecasts as sales of two key drugs topped expectations.

  • Major Indexes Fall Back Into Bear Territory Monday, 28 Jul 2008 | 5:03 PM ET

    Stocks declined Monday, led by financials after two more banks folded. Oil ticked higher after three straight weeks of decline, clipping consumer-discretionary stocks, including homebuilders, airlines and retailers.

  • Options Action: Merrill, Amgen, Medicals Monday, 28 Jul 2008 | 4:10 PM ET

    Merrill Lynch, Amgen, and some medical instrument outfits are getting a lot of options action this week, according to one observer.

  • Pipeline Of Profits! Monday, 28 Jul 2008 | 4:00 PM ET
    graphic_fast_money.jpg

    Pete Najarian reveals 3 biotechs he feels provide the most bang for the buck?

  • Financials Lead Decline After Bank Failures Monday, 28 Jul 2008 | 3:44 PM ET

    Stocks declined Monday, led by financials after two more banks folded. Oil ticked higher after three straight weeks of decline.

  • Stocks Trade Mixed as Oil Rises, Banks Wobble Monday, 28 Jul 2008 | 11:02 AM ET

    Stocks were mixed Monday as banks rallied and oil gained more than $1 a barrel.

  • Amgen Shares Leap on Osteoporosis Trial Results Monday, 28 Jul 2008 | 10:49 AM ET

    Shares of Amgen surged after the company reported positive trial results for its osteoporosis drug candidate denosumab—which one analyst terms "a future blockbuster."

  • Amgen's D-mab Delights Monday, 28 Jul 2008 | 10:38 AM ET
    AMGEN

    Amgen surprised the market late on a summer Friday by announcing positive test results from the big, crucial study of its experimental osteoporosis drug. The stock shot up after hours and continues to rally this morning.

  • Markets Best Sector Friday, 25 Jul 2008 | 6:52 PM ET

    In the last month healthcare has emerged as the best performing sector in the S&P. Are drug makers a cure for your portfolio in this economic downturn?

  • Friday's Top Videos: Gold, WaMu & More Friday, 25 Jul 2008 | 6:06 PM ET

    An analyst predicts that gold will head into a bull market, and Washington Mutual increases its liquidity position. The following are today's top videos:

  • Amgen Shares Leap on Osteoporosis Trial Results Friday, 25 Jul 2008 | 5:27 PM ET

    Amgen shares leaped in late trading Friday after the company said a pivotal trial of its experimental osteoporosis drug denosumab met its goal of significantly reducing the risk of bone fracture in post-menopausal women.

  • Best Trades Now: Tech, Utilities, Financials & More Thursday, 24 Jul 2008 | 3:30 PM ET

    To give investors an edge, CNBC asked the market experts for their best trades now.

  • Fannie, Freddie Rattle Market Friday, 11 Jul 2008 | 6:12 PM ET
    graphic_word_ofthe_street.jpg

    Fearing the two largest U.S. mortgage finance companies need a government bailout, investors pushed stocks lower Friday. What's the "Word On The Street?"

  • Pfizer, Merck And Lilly Partner Up To Get "Enlightened" Thursday, 10 Jul 2008 | 10:30 AM ET
    pfizer_hq.jpg

    Big pharma makes strange bedfellows. Pfizer, Merck and Eli Lilly this morning announced they've launched a joint venture of sorts called, "Enlight Biosciences". They're doing it with the help of the Boston-based VC firm PureTech Ventures.

  • Stocks Drop Into Official Bear Market Wednesday, 9 Jul 2008 | 6:06 PM ET
    graphic_word_ofthe_street.jpg

    The S&P closed 20% below its all-time high set in October, making it the last of the three major U.S. stock indexes to fall into a bear market. What's the "Word on the Street?"

  • During the short holiday week, volatility ruled the markets, impacted by record oil prices, economic data, the auto industry and financials.  How did the markets stack up?

  • Readers Get Short With Me--Over Amgen Thursday, 3 Jul 2008 | 11:08 AM ET

    Ahead of the long holiday weekend I thought this would be as good a time as any to once again go through the "Pharma's Market" mailbag. A couple of blog readers complained about my "short" story about Amgen.

  • Biopharma Analyst Musical Chairs Wednesday, 2 Jul 2008 | 11:16 AM ET
    cadeuses2.jpg

    In the world of nearly 400 publicly-traded biotechs, analyst coverage is especially important. Many of the firms are micro caps and when an analyst initiates coverage it can help put a baby biotech on investor and reporter radar screens.